Thrive Capital Management (Pennsylvania)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.41M | Buy |
30,763
+14,029
| +84% | +$1.56M | 1.07% | 27 |
|
|
2025
Q1 | $1.87M | Sell |
16,734
-11,451
| -41% | -$1.28M | 1.12% | 17 |
|
|
2024
Q4 | $2.6M | Buy |
28,185
+2,853
| +11% | +$264K | 1.19% | 27 |
|
|
2024
Q3 | $2.12M | Sell |
25,332
-4,371
| -15% | -$366K | 1% | 22 |
|
|
2024
Q2 | $2.04M | Buy |
29,703
+12,186
| +70% | +$836K | 0.93% | 27 |
|
|
2024
Q1 | $1.28M | Buy |
17,517
+14,731
| +529% | +$1.08M | 0.68% | 25 |
|
|
2023
Q4 | $226K | Sell |
2,786
-219
| -7% | -$17.7K | 0.12% | 134 |
|
|
2023
Q3 | $225K | Buy |
3,005
+87
| +3% | +$6.52K | 0.12% | 123 |
|
|
2023
Q2 | $225K | Sell |
2,918
-1,900
| -39% | -$146K | 0.13% | 125 |
|
|
2023
Q1 | $392K | Sell |
4,818
-3,987
| -45% | -$325K | 0.25% | 75 |
|
|
2022
Q4 | $756K | Sell |
8,805
-1,461
| -14% | -$125K | 0.49% | 44 |
|
|
2022
Q3 | $633K | Buy |
10,266
+4,425
| +76% | +$273K | 0.43% | 48 |
|
|
2022
Q2 | $361K | Buy |
+5,841
| New | +$361K | 0.25% | 66 |
|